Yonah (@tehrani_md) header
Yonah (@tehrani_md) profile picture

Husband Father Doctor Entrepreneur

Joined November 2011
Photo by Yonah (@tehrani_md)Photo by Yonah (@tehrani_md)Photo by Yonah (@tehrani_md)Photo by Yonah (@tehrani_md)Photo by Yonah (@tehrani_md)Photo by Yonah (@tehrani_md)Photo by Yonah (@tehrani_md)Photo by Yonah (@tehrani_md)Photo by Yonah (@tehrani_md)Photo by Yonah (@tehrani_md)
In ASCVD patients, is LDL <70 mg/dL good enough — or should we push harder to <55? Ez-PAVE trial (NEJM) delivers a clear answer: intensive targeting cuts major events by 33%. Practice-changing for secondary prevention?
11
GAME-CHANGER in VTE management just dropped in NEJM. Apixaban cuts clinically relevant bleeding by >50% compared to rivaroxaban in acute PE/DVT #Cardiology #VTE #DOAC #Anticoagulation #MedicalEducation #HeartHealth #MedTwitter #CardioTwitter #JACC #NEJM #AHA #ESC
31
FIRST dedicated Acute PE guideline (AHA/ACC 2026) just dropped! Old: Vague risk → inconsistent escalation. Categories A–E (shock + RV strain + biomarkers) + early PERT call for intermediate/high-risk. Blood thinners first; advanced Rx selective → fewer bleeds, more lives saved.
12
🚨 Cardiologists: Old rule = tolerate low-normal K+ in ICD pts to dodge hyperK fears. New POTCAST reality (NEJM): Push to high-normal (4.5–5.0 mmol/L) → ~31% ↓ in VT/ICD shocks, arrh/HF hosp, or death. Cheap K+ boost or MRA tweak = big arrhythmia protection. #Cardiology #EPeeps
34
TOP-CABG trial shows 3-month ticagrelor-based DAPT post-CABG is NONINFERIOR to 12 months for saphenous vein graft patency — AND slashes clinically relevant bleeding (8.3% vs 13.2%)! 🫀🩸 Would you shorten DAPT in your next CABG patient? Drop thoughts below! #DAPT #CABG
12
BREAKING HF STRATEGY UPDATE 📢 A single polypill for HFrEF significantly improved heart function, symptoms, quality of life & cut hospital visits vs separated meds. #heartfailure #Cardiology #Medicine #pharmacy
13
1️⃣ 🚨 LANDMARK PRIMARY PREVENTION BREAKTHROUGH 🧠💥 A PCSK9 inhibitor has now been shown to reduce first heart attack & stroke risk in high-risk patients with NO prior MI or stroke.
2
27
8️⃣ Takeaway: this could redefine risk-based therapy earlier in disease progression.
1
15
9️⃣ How will this change your preventive strategy in high-risk patients? 👇
13
NEW CARDIOLOGY DISCOVERY Patients with chest pain and normal coronary angiograms may still have true angina from microvascular disease — detectable with stress cardiac MRI! 🧠 This may change how we approach “normal cath results.” #Cardiology #Angina #aha #HeartHealth
1
21
🚀 BREAKTHROUGH in Heart Health Tech! AI + smartwatch ECG can now detect structural heart disease including LV dysfunction, valve damage & hypertrophy from a single-lead reading! #Cardiology #AIHealth #Smartwatch #HeartDisease #MedTwitter #DigitalHealth #AHA25 #Wearables
16
💥 NEW CARDIOLOGY FINDING 💥 Personalized vitamin D3 supplementation tailored to optimal blood levels cuts second heart attack risk by ~50% in survivors! 🩺💊 This could change post-MI care forever. #Cardiology #HeartAttack #VitaminD #HeartHealth #AHA25 #MedTwitter #PreventiveMed
32
🚨 BREAKTHROUGH: In high-risk patients without prior MI/stroke, adding evolocumab to statin therapy cut first major CV event risk by 25%! 💥 A landmark step in primary prevention for ASCVD & diabetics. #Cardiology #PreventiveCardio #PCSK9 #Evolocumab #HeartHealth #LipidTherapy
17